{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:27:50Z","timestamp":1794652070082,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["YQ2020H010"],"award-info":[{"award-number":["YQ2020H010"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["YQ2020H019"],"award-info":[{"award-number":["YQ2020H019"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","award":["2019-YQ-03"],"award-info":[{"award-number":["2019-YQ-03"]}],"id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["(CIFMS) 2019-I2M-5-078"],"award-info":[{"award-number":["(CIFMS) 2019-I2M-5-078"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Heart failure (HF) patients in general have a higher risk of developing cancer. Several animal studies have indicated that cardiac remodeling and HF remarkably accelerate tumor progression, highlighting a cause-and-effect relationship between these two disease entities. Targeting ferroptosis, a prevailing form of non-apoptotic cell death, has been considered a promising therapeutic strategy for human cancers. Exosomes critically contribute to proximal and distant organ-organ communications and play crucial roles in regulating diseases in a paracrine manner. However, whether exosomes control the sensitivity of cancer to ferroptosis via regulating the cardiomyocyte-tumor cell crosstalk in ischemic HF has not yet been explored. Here, we demonstrate that myocardial infarction (MI) decreased the sensitivity of cancer cells to the canonical ferroptosis activator erastin or imidazole ketone erastin in a mouse model of xenograft tumor. Post-MI plasma exosomes potently blunted the sensitivity of tumor cells to ferroptosis inducers both in vitro in mouse Lewis lung carcinoma cell line LLC and osteosarcoma cell line K7M2 and in vivo with xenograft tumorigenesis model. The expression of miR-22-3p in cardiomyocytes and plasma-exosomes was significantly upregulated in the failing hearts of mice with chronic MI and of HF patients as well. Incubation of tumor cells with the exosomes isolated from post-MI mouse plasma or overexpression of miR-22-3p alone abrogated erastin-induced ferroptotic cell death in vitro. Cardiomyocyte-enriched miR-22-3p was packaged in exosomes and transferred into tumor cells. Inhibition of cardiomyocyte-specific miR-22-3p by AAV9 sponge increased the sensitivity of cancer cells to ferroptosis. ACSL4, a pro-ferroptotic gene, was experimentally established as a target of miR-22-3p in tumor cells. Taken together, our findings uncovered for the first time that MI suppresses erastin-induced ferroptosis through releasing miR-22-3p-enriched exosomes derived from cardiomyocytes. Therefore, targeting exosome-mediated cardiomyocyte\/tumor pathological communication may offer a novel approach for the ferroptosis-based antitumor therapy.<\/jats:p>","DOI":"10.1038\/s41392-023-01336-4","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:02:23Z","timestamp":1679864543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Exosomes secreted from cardiomyocytes suppress the sensitivity of tumor ferroptosis in ischemic heart failure"],"prefix":"10.1038","volume":"8","author":[{"given":"Ye","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongting","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhezhe","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiwu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhuan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"1336_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/cvr\/cvz035","volume":"115","author":"WC Meijers","year":"2019","unstructured":"Meijers, W. C. & de Boer, R. A. Common risk factors for heart failure and cancer. Cardiovasc. Res. 115, 844\u2013853 (2019).","journal-title":"Cardiovasc. Res."},{"key":"1336_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jacc.2016.04.053","volume":"68","author":"T Hasin","year":"2016","unstructured":"Hasin, T. et al. Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer. J. Am. Coll. Cardiol. 68, 265\u2013271 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1336_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jacc.2013.04.088","volume":"62","author":"T Hasin","year":"2013","unstructured":"Hasin, T. et al. Patients with heart failure have an increased risk of incident cancer. J. Am. Coll. Cardiol. 62, 881\u2013886 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1336_CR4","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ejhf.472","volume":"18","author":"A Banke","year":"2016","unstructured":"Banke, A. et al. Incidence of cancer in patients with chronic heart failure: a long-term follow-up study. Eur. J. Heart Fail. 18, 260\u2013266 (2016).","journal-title":"Eur. J. Heart Fail."},{"key":"1336_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41591-020-0964-7","volume":"26","author":"GJ Koelwyn","year":"2020","unstructured":"Koelwyn, G. J. et al. Myocardial infarction accelerates breast cancer via innate immune reprogramming. Nat. Med. 26, 1452\u20131458 (2020).","journal-title":"Nat. Med."},{"key":"1336_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.117.030816","volume":"138","author":"WC Meijers","year":"2018","unstructured":"Meijers, W. C. et al. Heart Failure Stimulates Tumor Growth by Circulating Factors. Circulation 138, 678\u2013691 (2018).","journal-title":"Circulation"},{"key":"1336_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.120.046471","volume":"142","author":"S Avraham","year":"2020","unstructured":"Avraham, S. et al. Early Cardiac Remodeling Promotes Tumor Growth and Metastasis. Circulation 142, 670\u2013683 (2020).","journal-title":"Circulation"},{"key":"1336_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"1336_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou, Y. et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J. Hematol. Oncol. 12, 34 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"1336_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C., Liu, X., Jin, S., Chen, Y. & Guo, R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer 21, 47 (2022).","journal-title":"Mol. Cancer"},{"key":"1336_CR11","doi-asserted-by":"publisher","first-page":"830561","DOI":"10.3389\/fonc.2022.830561","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Ferroptosis: A New Strategy for Cancer Therapy. Front. Oncol. 12, 830561 (2022).","journal-title":"Front. Oncol."},{"key":"1336_CR12","doi-asserted-by":"publisher","first-page":"32433","DOI":"10.1073\/pnas.2006828117","volume":"117","author":"JY Lee","year":"2020","unstructured":"Lee, J. Y. et al. Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer. Proc. Natl Acad. Sci. USA 117, 32433\u201332442 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1336_CR13","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.7150\/thno.55482","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma. Theranostics 11, 5650\u20135674 (2021).","journal-title":"Theranostics"},{"key":"1336_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez, S. W. et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 551, 639\u2013643 (2017).","journal-title":"Nature"},{"key":"1336_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-biochem-013118-111902","volume":"88","author":"DM Pegtel","year":"2019","unstructured":"Pegtel, D. M. & Gould, S. J. Exosomes. Annu. Rev. Biochem. 88, 487\u2013514 (2019).","journal-title":"Annu. Rev. Biochem."},{"key":"1336_CR16","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","volume":"30","author":"MA Mori","year":"2019","unstructured":"Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandao, B. B. & Kahn, C. R. Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease. Cell Metab. 30, 656\u2013673 (2019).","journal-title":"Cell Metab."},{"key":"1336_CR17","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.7150\/thno.37357","volume":"9","author":"J Zhu","year":"2019","unstructured":"Zhu, J. et al. Exosomes from nicotine-stimulated macrophages accelerate atherosclerosis through miR-21-3p\/PTEN-mediated VSMC migration and proliferation. Theranostics 9, 6901\u20136919 (2019).","journal-title":"Theranostics"},{"key":"1336_CR18","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbcan.2019.04.004","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang, L. & Yu, D. Exosomes in cancer development, metastasis, and immunity. Biochim. Biophys. Acta Rev. Cancer 1871, 455\u2013468 (2019).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"1336_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01168-8","volume":"19","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer. Mol. Cancer 19, 43 (2020).","journal-title":"Mol. Cancer"},{"key":"1336_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/CIRCRESAHA.114.300639","volume":"114","author":"S Sahoo","year":"2014","unstructured":"Sahoo, S. & Losordo, D. W. Exosomes and cardiac repair after myocardial infarction. Circ. Res. 114, 333\u2013344 (2014).","journal-title":"Circ. Res."},{"key":"1336_CR21","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1172\/JCI123135","volume":"129","author":"L Qiao","year":"2019","unstructured":"Qiao, L. et al. microRNA-21-5p dysregulation in exosomes derived from heart failure patients impairs regenerative potential. J. Clin. Invest. 129, 2237\u20132250 (2019).","journal-title":"J. Clin. Invest."},{"key":"1336_CR22","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"1336_CR23","doi-asserted-by":"publisher","first-page":"590226","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen, X., Yu, C., Kang, R. & Tang, D. Iron Metabolism in Ferroptosis. Front. Cell Dev. Biol. 8, 590226 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1336_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"1336_CR25","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.bbagen.2012.03.017","volume":"1820","author":"AV Vlassov","year":"2012","unstructured":"Vlassov, A. V., Magdaleno, S., Setterquist, R. & Conrad, R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 1820, 940\u2013948 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"1336_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/CIRCRESAHA.116.309202","volume":"119","author":"M Ackers-Johnson","year":"2016","unstructured":"Ackers-Johnson, M. et al. A Simplified, Langendorff-Free Method for Concomitant Isolation of Viable Cardiac Myocytes and Nonmyocytes From the Adult Mouse Heart. Circ. Res. 119, 909\u2013920 (2016).","journal-title":"Circ. Res."},{"key":"1336_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S. et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13, 91\u201398 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"1336_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-60761-863-8_3","volume":"676","author":"Z Wang","year":"2011","unstructured":"Wang, Z. The principles of MiRNA-masking antisense oligonucleotides technology. Methods Mol. Biol. 676, 43\u201349 (2011).","journal-title":"Methods Mol. Biol."},{"key":"1336_CR29","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/ejhf.1539","volume":"21","author":"RA de Boer","year":"2019","unstructured":"de Boer, R. A., Meijers, W. C., van der Meer, P. & van Veldhuisen, D. J. Cancer and heart disease: associations and relations. Eur. J. Heart Fail. 21, 1515\u20131525 (2019).","journal-title":"Eur. J. Heart Fail."},{"key":"1336_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.molmed.2020.08.010","volume":"27","author":"M Conrad","year":"2021","unstructured":"Conrad, M., Lorenz, S. M. & Proneth, B. Targeting Ferroptosis: New Hope for As-Yet-Incurable Diseases. Trends Mol. Med. 27, 113\u2013122 (2021).","journal-title":"Trends Mol. Med."},{"key":"1336_CR31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41418-022-00957-6","volume":"29","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. Ubiquitin ligase E3 HUWE1\/MULE targets transferrin receptor for degradation and suppresses ferroptosis in acute liver injury. Cell Death Differ. 29, 1705\u20131718 (2022).","journal-title":"Cell Death Differ."},{"key":"1336_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli, J. P., Krysko, D. V. & Conrad, M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat. Rev. Cancer 19, 405\u2013414 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"1336_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1161\/CIRCULATIONAHA.118.033603","volume":"138","author":"E Bertero","year":"2018","unstructured":"Bertero, E., Canepa, M., Maack, C. & Ameri, P. Linking Heart Failure to Cancer: Background Evidence and Research Perspectives. Circulation 138, 735\u2013742 (2018).","journal-title":"Circulation"},{"key":"1336_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"He, C., Zheng, S., Luo, Y. & Wang, B. Exosome Theranostics: Biology and Translational Medicine. Theranostics 8, 237\u2013255 (2018).","journal-title":"Theranostics"},{"key":"1336_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/CIRCRESAHA.121.320157","volume":"130","author":"L Gan","year":"2022","unstructured":"Gan, L. et al. Ischemic Heart-Derived Small Extracellular Vesicles Impair Adipocyte Function. Circ. Res. 130, 48\u201366 (2022).","journal-title":"Circ. Res."},{"key":"1336_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang, D., Chen, X., Kang, R. & Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 31, 107\u2013125 (2021).","journal-title":"Cell Res."},{"key":"1336_CR37","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1158\/0008-5472.CAN-21-3230","volume":"82","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer. Cancer Res. 82, 2254\u20132268 (2022).","journal-title":"Cancer Res."},{"key":"1336_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-21-0728","volume":"21","author":"J Li","year":"2022","unstructured":"Li, J. et al. Small-Molecule MMRi62 Induces Ferroptosis and Inhibits Metastasis in Pancreatic Cancer via Degradation of Ferritin Heavy Chain and Mutant p53. Mol. Cancer Ther. 21, 535\u2013545 (2022).","journal-title":"Mol. Cancer Ther."},{"key":"1336_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.09.014","volume":"522","author":"Y Lu","year":"2021","unstructured":"Lu, Y. et al. KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. Cancer Lett. 522, 1\u201313 (2021).","journal-title":"Cancer Lett."},{"key":"1336_CR40","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen, X., Li, J., Kang, R., Klionsky, D. J. & Tang, D. Ferroptosis: machinery and regulation. Autophagy 17, 2054\u20132081 (2021).","journal-title":"Autophagy"},{"key":"1336_CR41","doi-asserted-by":"publisher","first-page":"16262","DOI":"10.1096\/fj.202001758R","volume":"34","author":"Y Xu","year":"2020","unstructured":"Xu, Y., Li, X., Cheng, Y., Yang, M. & Wang, R. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion. FASEB J. 34, 16262\u201316275 (2020).","journal-title":"FASEB J."},{"key":"1336_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1101\/sqb.2006.71.050","volume":"71","author":"E Lund","year":"2006","unstructured":"Lund, E. & Dahlberg, J. E. Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs. Cold Spring Harb. symp. Quant. Biol. 71, 59\u201366 (2006).","journal-title":"Cold Spring Harb. symp. Quant. Biol."},{"key":"1336_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s13287-020-01707-6","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. Extracellular vesicle-encapsulated miR-22-3p from bone marrow mesenchymal stem cell promotes osteogenic differentiation via FTO inhibition. Stem Cell Res. Ther. 11, 227 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"1336_CR44","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ymthe.2021.02.009","volume":"29","author":"Y Feng","year":"2021","unstructured":"Feng, Y. et al. Tumor cell-secreted exosomal miR-22-3p inhibits transgelin and induces vascular abnormalization to promote tumor budding. Mol. Ther. 29, 2151\u20132166 (2021).","journal-title":"Mol. Ther."},{"key":"1336_CR45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.7150\/ijms.21645","volume":"15","author":"KT Lv","year":"2018","unstructured":"Lv, K. T. et al. MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells. Int. J. Med. Sci. 15, 142\u2013152 (2018).","journal-title":"Int. J. Med. Sci."},{"key":"1336_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.yjmcc.2021.05.010","volume":"158","author":"Y Bian","year":"2021","unstructured":"Bian, Y. et al. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart. J. Mol. Cell. Cardiol. 158, 128\u2013139 (2021).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"1336_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03315-x","volume":"12","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y. et al. ALKBH5 suppresses tumor progression via an m(6)A-dependent epigenetic silencing of pre-miR-181b-1\/YAP signaling axis in osteosarcoma. Cell Death Dis. 12, 60 (2021).","journal-title":"Cell Death Dis."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01336-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01336-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01336-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T21:02:27Z","timestamp":1679864547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01336-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1336"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01336-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"1 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}